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Abstract
Objective: The present study aimed to investigate patients’ characteristics that can affect the
dose of propofol required to sedate children undergoing imaging.
Methods: In this retrospective, observational study, we reviewed medical records of children
aged 0 to 18 years who were classified as having American Society of Anesthesiologists status 1
or 2 and they underwent imaging under propofol sedation between January 2011 and August
2016. Collected data included patients’ demographics, propofol doses, duration of sedation, and
complications. Regression analysis was performed to determine patients’ characteristics that may
affect the dose of propofol required to induce sedation.
Results: A total of 925 patients were included. Simple linear regression showed that the dose of
propofol was correlated with age, height, weight, and body surface area. Using the results of
multiple linear regression, the following formula was used to estimate the dose of propofol (mg)
for sedation: 0.75þ 0.14 age (months)þ 45.82 body surface area (m2).
Conclusion: A child’s age, height, and body surface area should be considered when deciding the
induction dose of propofol. Additionally, the formula that we have proposed can be used to
estimate the dose of propofol required to induce sedation in children undergoing imaging.
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Introduction
Pediatric patients often undergo radiologi-
cal examinations, such as computed tomog-
raphy (CT) or magnetic resonance imaging
(MRI). Children must remain motionless
during such examinations so that accurate
imaging can be obtained. The long duration
of some imaging procedures, noise of the
machines, and anxiety caused by being
alone in a confined space can cause difficul-
ty for pediatric patients in remaining still.
Therefore, many children need to be sedat-
ed during radiological examinations.1,2
When sedating children, determining the
optimal dose of sedative medications is
essential.3,4 If the sedative dose is too low,
children may wake up or move during the
radiological examination, which can inter-
rupt the procedure and impede the ability
to obtain accurate imaging. Inadequately
sedated children can also fall from the
machine and become injured. Conversely,
if the sedative dose is too high, it can lead
to complications, such as hypotension,
apnea, and airway obstruction. Because of
anatomical and physiological differences,
children are more prone to these complica-
tions of sedation than adults.5,6 For these
reasons, physicians often struggle to deter-
mine the most appropriate sedative doses
for pediatric patients.
Sedative dosing strategies in children
should consider the condition of the child,
the type of examination or procedure, and
the predicted degree of pain. Propofol is
widely used for pediatric sedation owing
to its rapid onset and rapid recovery.7,8
However, there is no definitive guideline
regarding the dosage of propofol for chil-
dren undergoing radiological examina-
tions.9–11 Furthermore, the current
guideline suggests a range of propofol
doses for pediatric sedation based on only
the child’s body weight. The physician must
then choose the propofol dose within the
suggested range, depending on his or her
experience, preference, and the medical
condition of the child. Therefore, under-
standing which patients’ characteristics
can affect the sedative effect of propofol
in children undergoing sedation for radio-
logical examinations would be helpful.
The present study used regression analy-
sis of retrospectively collected data from
pediatric patients who successfully under-
went sedation for radiological examinations
without complications. This study aimed to
identify patients’ characteristics that may
affect the sedative effect of propofol. We
also proposed a formula, which might be
used as a reference to determine the propo-
fol dose required to induce sedation in chil-
dren undergoing radiological examinations.
Materials and Methods
Study population
In this retrospective, observational study,
we analyzed medical records of children
aged 0 to 18 years. These children were clas-
sified as having American Society of
Anesthesiologist physical status 1 or 2 with-
out complications and underwent propofol
sedation for either a CT or MRI scan at a
single tertiary medical center from 1
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January 2011 to 31 August 2016. Patients
were excluded from the analysis if they
received any sedatives other than propofol
before or during the examination, if there
was evidence of a respiratory infection or
uncorrected heart disease, or if there was
incomplete documentation regarding demo-
graphic data or propofol dosing. The study
protocol was approved by the ethics com-
mittee of Severance Hospital Yonsei
University (IRB no.: 4-2016-0733).
Informed consent was not required because
this was a retrospective study.
Pediatric sedation protocol
Oxygen saturation by pulse oximetry, an
electrocardiogram, non-invasive blood
pressure, and end-tidal carbon dioxide
were monitored throughout the radiological
examinations. Patients received an intrave-
nous injection of 0.004 mg/kg of glycopyr-
rolate followed by 1.5 mg/kg of propofol.
Loss of consciousness was defined as the
absence of the eye lash reflex or the ability
to apply a face mask without the child
resisting. The sedation level was maintained
at 4 to 6 points using the Modified Ramsay
Sedation Scale. If the patient remained con-
scious, an additional 0.5 to 1.0 mg/kg of
propofol was administered every minute
until loss of consciousness was achieved.
For examinations lasting longer than 20
minutes, a continuous infusion of propofol
was administered at a rate of 25 to 100 mg/
kg/minute. An additional dose of propofol
was administered if the patient regained
consciousness or moved during the
examination.
Patients were transferred to the post-
anesthesia recovery room after the radio-
logical examinations. They were discharged
when their hemodynamic values remained
at 20% of baseline, their modified Aldrete
recovery score was at least 9 points, they
were fully conscious, and they could con-
sume water without nausea or vomiting.
Data collection
Collected medical record data included
demographic information (sex, age,
weight, height, and body surface area
[BSA]), diagnosis, type of procedure, total
duration of the radiological examination,
initial dose of propofol, additional doses
of propofol and injection times, and total
dose of propofol administered.
Information on the incidence of complica-
tions, such as respiratory depression,
airway obstruction, hypotension, bradycar-
dia, and aspiration, was also collected. In
this study, BSA was defined as follows:ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
weight kgð Þ  height ðcmÞ=3600p .
Successful sedation was defined as the loss
of consciousness after injection of propofol,
as well as no recovery of consciousness,
considerable movement, or complications
during the examination. The dose of propo-
fol required to induce sedation was defined
as the total dose administered until the
patient lost consciousness. Respiratory
depression was defined as the occurrence
of desaturation (oxygen saturation by
pulse oximetry< 90%), hypercapnia (end-
tidal carbon dioxide> 50mmHg), or
apnea. Hypotension and bradycardia were
diagnosed on the basis of normal values of
blood pressure and pulse rate for the
patient’s age. Children who experienced
sedation-related complications were exclud-
ed from the regression analysis.
Statistical analysis
Linear regression analysis was used to
determine the relationships between the
patient’s sex, age, weight, height, BSA and
the dose of propofol required to induce
sedation. The results of regression analysis
were then used to determine a formula that
can estimate the dose of propofol required
to induce sedation in children undergoing
radiological examinations. The variance
inflation factor (VIF) was checked for
Min et al. 3
multiple collinearity before performing
multiple linear regression. Multiple collin-
earity among independent variables, as
indicated by a VIF value> 10, indicated
that these variables could not be analyzed
simultaneously using a single model.
Therefore, these variables were analyzed
using different models. Each model was
visually inspected for linearity, heterosce-
dasticity, and normality of the residuals.
Residual analysis was also performed
using a studentized residual to verify
normal distribution and isodispersion. A
probability–probability plot was used to
evaluate the skewness of the distribution.
All analyses were performed using SAS ver-
sion 9.4 (SAS Inc., Cary, NC, USA).
Results
After reviewing the medical records, 925
cases of successful sedation were included
in the regression analysis. Table 1 shows
the demographic data of the included
patients. The median dose of propofol
required to induce sedation was 2 mg/kg
(interquartile ratio, 2–2.8 mg/kg).
Simple linear regression analysis was
performed to investigate the relationships
between the dose of propofol required to
induce sedation and sex, age, weight,
height, and BSA (Table 2). There were sig-
nificant associations between the dose of
propofol required to induce sedation and
age, weight, height, and BSA (all
p< 0.001). Figure 1 shows scatter plots of
the relationships between the dose of pro-
pofol required to induce sedation and the
patients’ characteristics. The scatter plots
show a tendency for the slope of the propo-
fol dose to increase with increasing age,
weight, height, and BSA.
Multiple linear regression analysis was
performed to determine the relationships
between the dose of propofol required to
induce sedation and two or more character-
istics of children other than sex. The VIF of
Table 1. Characteristics of the 925 children





Median age, months 28.2 (12.6–52.8)
Median weight, kg 12 (9–16)
Median height, cm 89 (74.6–103)





CT 218 ( 23.6)
MRI 700 ( 75.7)
CTþMRI 7 ( 0.7)
Imaging site
Brain 476 (51.4)





Values are median (interquartile range) or number (%).
BSA, body surface area; ASA, American Society of
Anesthesiologists; CT, computed tomography; MRI, mag-
netic resonance imaging.
Table 2. Simple linear regression analysis between
demographic data and the dose of propofol
required to induce sedation for children during
radiological examinations
Dose of propofol required
to induce sedation
b (SE) p value
Sex 0.083 (1.044) 0.937
Age (months) 0.421 (0.013) <0.001
Height (cm) 0.512 (0.020) <0.001
Weight (kg) 1.805 (0.052) <0.001
BSA (m2) 63.867 (1.838) <0.001
SE, standard error; BSA, body surface area.
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age, weight, height, and BSA was 5.7, 147.9,
43.9, and 318.8, respectively. The VIF of
weight, height, and BSA showed multiple
collinearity. Therefore, we were not able
to simultaneously analyze these variables
using the same model. Consequently, we
used three models of age and weight togeth-
er, age and height together, and age and
BSA together (Table 3). Among the three
models, the model of age and BSA had the
highest adjusted R2 value (0.612).
Therefore, this model was selected as the
best formula for estimating the dose of
propofol required to induce sedation in
children undergoing radiological examina-
tions. The formula for estimating the pro-
pofol induction dose (mg) is as
follows: 0.75þ 0.14 age (months)þ
45.82BSA (m2).
As shown in Figure 2, the data
points appeared to be random with no par-
ticular tendency centering around zero.
Figure 1. Simple linear regression between demographic characteristics and the dose of propofol required
to induce sedation in children undergoing radiological examinations. (A) Age, (B) weight, (C) height, and
(D) BSA
BSA, body surface area.
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In addition, the probability–probability
plot showed a nearly linear pattern, which
indicated that normal distribution was an
appropriate model for this data set
(Figure 3).
Discussion
Several studies have evaluated the dose of
propofol required for pediatric sedation.12
However, these studies were performed in
children who underwent various types of
examinations and procedures. Unlike
other types of examinations or procedures,
children undergoing radiological
examinations, such as CT or MRI, do not
require an analgesic effect, but remaining
motionless during the examination is cru-
cial. Therefore, in this investigation, we
focused on determining the propofol dose
required to induce sedation in children
undergoing radiological examinations.
To determine the propofol dose required
to induce sedation in children undergoing
radiological examinations, we performed
regression analysis of data from the medical
records of children who underwent success-
ful sedation for radiological examinations.
We found that, in addition to weight, age,
height, and BSA affected the dose of
Table 3. Regression equations describing the dose of propofol required to induce sedation taking into
account age and other demographics (height, weight, and BSA)
Variables Equation Adjusted R2
Age, height 1.88þ 0.28 age (months)þ 0.236 height (cm) 0.571
Age, weight 10.70þ 0.19 age (months)þ 1.13weight (kg) 0.596
Age, BSA 0.75þ 0.14 age (months)þ 45.82BSA (m2) 0.612
BSA, body surface area.
Figure 2. Residual plot between standardized and predicted values. The dependent variable was the
induction dose of propofol for pediatric sedation
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propofol required to induce sedation in
children. Using the results of the regression
analysis, we found that the following for-
mula can be used to estimate the dose of
propofol required to induce sedation in
children undergoing a radiological exami-
nation: 0.75þ 0.14 age (months)þ
45.82BSA (m2).
Current guidelines suggest that the dose
of propofol required to induce pediatric
sedation should be based only on the
patient’s weight.12,13 However, weight does
not represent all aspects of a child’s growth
and development. The present study sug-
gests that age and BSA should be consid-
ered together when determining the dose of
propofol required to induce sedation in
pediatric patients undergoing radiological
examinations. The results of the present
study are consistent with those of a previ-
ous study by Karalea et al.14 However, in
the present study, we reviewed more medi-
cal records of successfully sedated children
than in Karalea et al.’s study14, and the
children in our study only underwent radio-
logical examinations.
Pharmacokinetic characteristics of pro-
pofol, such as volume of distribution and
clearance, are affected by body composi-
tion, maturation of organ function, altered
protein binding, and underlying disease.
Children have a relatively larger volume of
distribution and clearance than adults, and
these characteristics change as the child
grows.15 Therefore, unsurprisingly, age
was a significant factor in the regression
model in our study.
In the present study, we also found that
BSA should be included in the regression
formula to estimate the propofol dose
required to induce sedation in children
undergoing radiological examinations.
Figure 3. Probability–probability plot for the induction dose of propofol in children undergoing radiological
examinations. The dependent variable was the induction dose of propofol for pediatric sedation
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There may be several reasons that including
the child’s BSA in the formula shows a
higher R2 value than only including the
child’s weight. BSA is correlated with
metabolic rate, which is proportional to
drug redistribution and metabolism.
Furthermore, the volume of drug distribu-
tion is closely associated with extracellular
fluid volume, which is more closely corre-
lated with BSA than weight. Therefore,
BSA should be considered when deciding
the dose of propofol required to sedate chil-
dren for radiological examinations.16–19
In our study, the initial propofol dose
administered was 1.5 mg/kg, which was fol-
lowed by an additional 0.5 to 1.0 mg/kg
every minute until loss of consciousness
was achieved. Because the recorded dose
of propofol might exceed the minimal
dose required to induce sedation, we only
included data from patients with no
sedation-related complications. Therefore,
the formula proposed in the present study
may help physicians choose the optimal
dose of propofol required to sedate children
for radiological procedures.
Importantly, the present study only
included children who underwent imaging
studies, such as CT or MRI scans. There
is generally no pain during such imaging
studies, but children should remain motion-
less so that accurate imaging can be
obtained. Other types of procedures for
which children require sedation, such as
reduction of fractures and laceration
repair, require an analgesic effect and may
require the child’s cooperation. Therefore,
caution should be used when applying the
formula proposed in this study to children
undergoing sedation for non-radiological
procedures.
The present study has several limitations.
First, the data were retrospectively obtained
from medical records. However, these data
were recorded in detail as part of a quality
improvement effort regarding pediatric
sedation. Second, the data were recorded
by pediatric sedation providers, which
may have affected the results. Third, only
healthy children classified as having
American Society of Anesthesiologist phys-
ical status 1 or 2 were included in this anal-
ysis. Therefore, caution should be used
when applying the results of this study to
children who may be more susceptible to
propofol-related complications. Finally,
we did not take into account the effects of
other medications that children were taking
on the sedative effect of propofol.
Conclusions
In addition to weight, age, height, and BSA
should be considered when deciding
the dose of propofol required to sedate chil-
dren for radiological examinations.
Additionally, we have proposed a formula
that can be used to estimate the dose of
propofol required to induce sedation in
children undergoing radiological examina-
tions. However, further clinical investiga-
tions are required to validate this formula.
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